Acadia Healthcare (NASDAQ:ACHC) Sets New 1-Year Low on Analyst Downgrade

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) reached a new 52-week low on Thursday after Royal Bank Of Canada lowered their price target on the stock from $28.00 to $22.00. Royal Bank Of Canada currently has an outperform rating on the stock. Acadia Healthcare traded as low as $16.91 and last traded at $17.2560, with a volume of 48066 shares traded. The stock had previously closed at $17.41.

Other equities research analysts have also recently issued reports about the company. Guggenheim lowered their target price on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a report on Monday. Raymond James Financial set a $22.00 target price on Acadia Healthcare in a research report on Friday, November 7th. Cantor Fitzgerald decreased their price target on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Finally, UBS Group reduced their price target on shares of Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $32.82.

Check Out Our Latest Stock Report on Acadia Healthcare

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. Allworth Financial LP increased its position in Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company’s stock valued at $38,000 after purchasing an additional 1,234 shares during the period. Hantz Financial Services Inc. increased its stake in Acadia Healthcare by 501.9% in the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after acquiring an additional 1,822 shares during the last quarter. Finally, CWM LLC increased its stake in shares of Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after buying an additional 1,349 shares during the period.

Acadia Healthcare Price Performance

The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $23.02 and a two-hundred day simple moving average of $22.71. The stock has a market cap of $1.57 billion, a PE ratio of 11.26, a P/E/G ratio of 4.56 and a beta of 0.97.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Recommended Stories

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.